Lucas Primo de Carvalho Alves

Lucas Primo de Carvalho Alves

Auto-generated profile, based on publicly available information

Lucas Primo de Carvalho Alves

Universidade do Vale do Rio dos Sinos, Brazil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LALucas Primo de Carvalho Alves
Lucas Primo de Carvalho Alves
MFMarcelo Pio de Almeida Fleck
Marcelo Pio de Almeida Fleck
ABAline Boni
Aline Boni
NRNeusa Sica da Rocha
Neusa Sica da Rocha
Melancholic features of depression (MFD) seem to be a unidimensional group of signs and symptoms. However, little importance has been given to the evaluation of what features are related to a more severe disorder. That is, what are the MFD that appear only in the most depressed patients. We aim to demonstrate how each MFD is related to the severity of the major depressive disorder. We evaluated both the Hamilton depression rating scale (HDRS-17) and its 6-item melancholic subscale (HAM-D6) in 291 depressed inpatients using Rasch analysis, which computes the severity of each MFD. Overall measures of model fit were mean (±SD) of items and persons residual = 0 (±1); low χ2 value; p>0.01. For the HDRS-17 model fit, mean (±SD) of item residuals = 0.35 (±1.4); mean (±SD) of person residuals = -0.15 (±1.09); χ2 = 309.74; p<0.00001. For the HAM-D6 model fit, mean (±SD) of item residuals = 0.5 (±0.86); mean (±SD) of person residuals = 0.15 (±0.91); χ2 = 56.13; p = 0.196. MFD ordered by crescent severity were depressed mood, work and activities, somatic symptoms, psychic anxiety, guilt feelings, and psychomotor retardation. Depressed mood is less severe, while guilt feelings and psychomotor retardation are more severe MFD in a psychiatric hospitalization. Understanding depression as a continuum of symptoms can improve the understanding of the disorder and may improve its perspective of treatment.

1 January 2020 in Therapeutic Advances in Psychopharmacology
Verified
Journal Article
Open access
PDF file
LALucas Primo de Carvalho Alves
Lucas Primo de Carvalho Alves
NRNeusa Sica da Rocha
Neusa Sica da Rocha
Background: Six melancholic features (MFs) of the Hamilton Depression Rating Scale (HAM-D6) represent the construct of melancholia along a continuum of severity (from least to most severe: depressed mood, work and activities, somatic symptoms, psychic anxiety, guilty feelings, psychomotor retardation). We aimed to evaluate the association between these MFs and inflammatory cytokines (IC) in the blood. Methods: Each IC [interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α), interleukin 2 (IL-2), IL-4, IL-6, IL-10, and IL-17] was associated with the HAM-D6 MFs of 139 severely depressed inpatients, using multiple linear regressions adjusted for covariates. Levels were compared with those of 100 healthy controls. Results: Depressed mood was associated with higher levels of IL-4 ( β = 0.167; p = 0.041). Psychic anxiety: lower IL-17 levels ( β = –0.173; p = 0.039). Guilt feelings: lower IL-2 levels ( β = −0.168; p = 0.041) Psychomotor retardation: higher IL-6 levels ( β = 0.195; p = 0.017). Depressed patients’ TNF-α, INF-γ, and IL-4 levels were not significantly different from controls. Depressed patients’ IL-2, IL-6, IL-10, and IL-17 levels were higher than those of controls ( p <0.001). Conclusion: Less severe MFs (depressed mood, psychic anxiety, and guilt feelings) were associated with an anti-inflammatory pattern (higher IL-4, lower IL-17 and lower IL-2, respectively). The presence of the most severe MF, psychomotor retardation, was associated with a higher pro-inflammatory response (higher IL-6).


1 January 2024 in Jornal Brasileiro de Psiquiatria
Verified
Journal Article
Open access
PDF file
MGMaria Fernanda Ronchetti Grillo
Maria Fernanda Ronchetti Grillo
SCSamira Mohamad Bjaige Collins
Samira Mohamad Bjaige Collins
VZVanessa Regina Zandonai
Vanessa Regina Zandonai
GZGustavo Zeni
Gustavo Zeni
LALucas Primo de Carvalho Alves
Lucas Primo de Carvalho Alves
JSJuliana Nichterwitz Scherer
Juliana Nichterwitz Scherer
Introdução O surgimento ou agravamento de problemas e transtornos mentais durante a gravidez e o puerpério tem sido amplamente documentado na literatura e contribui significativamente para o aumento da morbimortalidade materno-fetal. O objetivo deste estudo foi realizar uma revisão de escopo da literatura para levantar as principais evidências de estudos brasileiros no âmbito da investigação de problemas de saúde mental em gestantes e puérperas, identificando os principais fatores de risco apontados na literatura.

1 January 2023 in Therapeutic Advances in Psychopharmacology
Verified
Journal Article
Open access
AJAntonio Augusto Schmitt Junior
Antonio Augusto Schmitt Junior
LALucas Primo de Carvalho Alves
Lucas Primo de Carvalho Alves
BPBarbara Larissa Padilha
Barbara Larissa Padilha
NRNeusa Sica da Rocha
Neusa Sica da Rocha
Background: There is increasing evidence of the association between chronic low-grade inflammation and severe mental illness (SMI). The objective of our study was to assess serum cytokine levels (SCLs) at admission and discharge in a true-to-life-setting population of inpatients with major depression (MD), bipolar disorder (BD), and schizophrenia (Sz), as well as of healthy controls. Methods: We considered MD, BD, and Sz to be SMIs. We evaluated 206 inpatients [MD, N = 92; BD, N = 26; mania (Ma), N = 44; Sz, N = 44). Generalized estimating equations were used to analyze variations in SCL [interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α), interleukin (IL)-2, IL-4, IL-6, IL-10, and IL-17] at hospital admission and discharge. Results of 100 healthy controls were compared with those of SMI patients at both time points. We evaluated patients’ improvement during in-hospital treatment in terms of general psychiatric symptoms, global clinical impression, functionality, and manic and depressive symptoms with validated scales. Results: In all, 68.9% of patients completed the study. Overall, SMI inpatients had higher SCL when compared with controls regardless of diagnosis. There was a significant decrease in Brief Psychiatric Rating Scale (BPRS) and Clinical Global Impression–Severity Scale (CGI-S) scores, and an increase in Global Assessment of Functioning (GAF) scores for all disorders evaluated ( p < 0.001), as well as a significant decrease in HDRS-17 scores among MD inpatients ( p < 0.001) and in YMRS scores among Ma inpatients ( p < 0.001). IL-2 and IL-6 levels decreased significantly between admission and discharge only among MD inpatients ( p = 0.002 and p = 0.03, respectively). We found no further statistically significant changes in SCL among the remaining disorders (BD, Ma, and Sz). There was no significant decrease in IFN-γ ( p = 0.64), TNF-α ( p = 0.87), IL-4 ( p = 0.21), IL-10 ( p = 0.88), and IL-17 ( p = 0.71) levels in any of the evaluated diagnoses. Conclusion: MD inpatients had a decrease in IL-2 and IL-6 levels during hospitalization, which was accompanied by clinical improvement. No associations were found for the remaining SMIs (BD, Ma, and Sz).

11 November 2016 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
LALucas P. C. Alves
Lucas P. C. Alves
TFThiago F. V. Freire
Thiago F. V. Freire
MFMarcelo P. A. Fleck
Marcelo P. A. Fleck
NRNeusa S. Rocha
Neusa S. Rocha
Naturalistic studies can be useful tools to understand how an intervention works in the real clinical practice. This study aims to investigate the outcomes in a naturalistically treated depressed inpatients cohort, who were referred, or not, to unilateral ECT. Depressed adults according to MINI admitted in a psychiatric unit were divided in unilateral ECT treated and non-ECT treated. Main outcomes were: depression improvement in Hamilton Rating Scale for Depression (HDRS-17) scores; response (HDRS-17 improvement ≥50 %); remission (HDRS-17 score ≤7); length of hospitalization. Forty-three patients were included in unilateral ECT group and 104 in non-ECT group. No differences of psychotic symptoms, melancholic features or past maniac episode were found between groups. Unilateral ECT group had a mean HDRS-17 score higher than non-ECT group at admission (ECT: 25.05 ± 1.03; non-ECT: 21.61 ± 0.69; p = 0.001), but no significant difference was found at discharge (ECT: 7.70 ± 0.81; non-ECT: 7.40 ± 0.51; p = 0.75). Unilateral ECT group had a larger HDRS-17 score reduction during treatment (ECT: 18.24 ± 1.18; non-ECT:14.20 ± 0.76; p = 0.004). There were no significant differences in response and remission rates between groups. Unilateral ECT group had longer mean duration of hospitalization in days (ECT: 35.48 ± 2.48; non-ECT: 24.57 ± 1.50; p < 0.001), but there were no difference in mean time of treatment (ECT group:27.66 ± 1.95; non-ECT: 24.57 ± 1.50; p = 0.25). Unilateral high-dose ECT is still a useful treatment option, in the real world clinical practice, to reduce the intensity of depressive symptoms in highly depressed inpatients.